{"id":"W3023738757","doi":"10.1016/s1470-2045(20)30061-9","title":"Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial","year":2020,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":127,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ottawa Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"National Cancer Institute; Manchester Biomedical Research Centre; Clovis Oncology; Memorial Sloan-Kettering Cancer Center; Stand Up To Cancer; Entertainment Industry Foundation; V Foundation for Cancer Research; University College London; American Association for Cancer Research","keywords":"Placebo; Medicine; Oncology; Internal medicine; Ovarian carcinoma; Ovarian cancer; Cancer; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001977658,0.0009584237,0.002179538,0.0002933754,0.0002617101,0.0009819462,0.0007281136,0.001308192,0.003680608],"category_scores_gemma":[0.002211552,0.0003167961,0.002593514,0.0005138862,0.0006391366,0.0009019218,0.0003175775,0.003616756,0.0006652802],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005946794,"about_ca_system_score_gemma":0.0005633294,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008553112,"about_ca_topic_score_gemma":0.002841712,"domain_scores_codex":[0.999357,0.0003302919,0.00004068791,0.00009829797,0.00007424939,0.00009942823],"domain_scores_gemma":[0.9989867,0.000360336,0.0003156432,0.00008264357,0.00006246253,0.0001922382],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8767667,0.002197511,0.003786667,0.002664204,0.007685514,0.0001226964,0.00008941632,0.000965005,0.003924002,0.0002864771,0.004195065,0.09731663],"study_design_scores_gemma":[0.9097472,0.06209037,0.01682545,0.0002137391,0.004136251,0.0002713957,0.00005428427,0.0008006977,0.0008808371,0.0005743382,0.004354632,0.00005074265],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9291712,0.05800636,0.0009543865,0.001926351,0.0008348307,0.001085893,0.002932698,0.0003134501,0.004774773],"genre_scores_gemma":[0.9796586,0.0110798,0.0009448361,0.002131433,0.000499759,0.0007190498,0.002538902,0.00004079986,0.002386858],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003680608,"threshold_uncertainty_score":0.01231289,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04068493652222073,"score_gpt":0.3485534876066515,"score_spread":0.3078685510844308,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}